GetTopicDetailResponse(id=e38c1081317, topicName=Lenvima, introduction=Lenvima, content=null, image=null, comments=5, allHits=1615, url=https://h5.medsci.cn/topic?id=10813, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=25437, tagList=[TagDto(tagId=25437, tagName=Lenvima)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1656409, encodeId=bd461656409cd, content=<a href='/topic/show?id=e38c1081317' target=_blank style='color:#2F92EE;'>#Lenvima#</a>, objectTitle=IKCS 2020：基于LENVIMA（lenvatinib）的聯(lián)合療法治療腎細(xì)胞癌, objectType=article, longId=203136, objectId=a3c920313621, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c920313621, replyNumber=0, likeNumber=64, createdTime=2021-03-13, rootId=0, userName=feather86, userId=86f624811659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c920313621, moduleTitle=IKCS 2020：基于LENVIMA（lenvatinib）的聯(lián)合療法治療腎細(xì)胞癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a3c920313621)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656408, encodeId=9dd71656408bc, content=<a href='/topic/show?id=e38c1081317' target=_blank style='color:#2F92EE;'>#Lenvima#</a>, objectTitle=Keytruda聯(lián)合Lenvima治療肝細(xì)胞癌（HCC）：遭遇滑鐵盧, objectType=article, longId=197268, objectId=1caa19e26835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1caa19e26835, replyNumber=0, likeNumber=96, createdTime=2021-03-07, rootId=0, userName=feather86, userId=86f624811659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1caa19e26835, moduleTitle=Keytruda聯(lián)合Lenvima治療肝細(xì)胞癌（HCC）：遭遇滑鐵盧, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1caa19e26835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656407, encodeId=f1f2165640e20, content=<a href='/topic/show?id=e38c1081317' target=_blank style='color:#2F92EE;'>#Lenvima#</a>, objectTitle=Eisai/MSD的Lenvima在歐洲被批準(zhǔn)用于肝癌的治療, objectType=article, longId=147384, objectId=744714e38490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744714e38490, replyNumber=0, likeNumber=90, createdTime=2019-04-06, rootId=0, userName=feather86, userId=86f624811659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744714e38490, moduleTitle=Eisai/MSD的Lenvima在歐洲被批準(zhǔn)用于肝癌的治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=744714e38490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656406, encodeId=c5c3165640613, content=<a href='/topic/show?id=e38c1081317' target=_blank style='color:#2F92EE;'>#Lenvima#</a>, objectTitle=諾華聯(lián)合衛(wèi)材將在美國(guó)推出抗癌藥Lenvima/Afinitor組合療法, objectType=article, longId=70375, objectId=c875e0375c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c875e0375c6, replyNumber=0, likeNumber=83, createdTime=2017-05-04, rootId=0, userName=feather86, userId=86f624811659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c875e0375c6, moduleTitle=諾華聯(lián)合衛(wèi)材將在美國(guó)推出抗癌藥Lenvima/Afinitor組合療法, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c875e0375c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656405, encodeId=85c716564050a, content=<a href='/topic/show?id=e38c1081317' target=_blank style='color:#2F92EE;'>#Lenvima#</a>, objectTitle=衛(wèi)材新型抗癌藥Lenvima獲日本批準(zhǔn)，將成為甲狀腺癌臨床治療新標(biāo)準(zhǔn), objectType=article, longId=48685, objectId=bdbd4868512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bdbd4868512, replyNumber=0, likeNumber=74, createdTime=2015-04-02, rootId=0, userName=feather86, userId=86f624811659, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bdbd4868512, moduleTitle=衛(wèi)材新型抗癌藥Lenvima獲日本批準(zhǔn)，將成為甲狀腺癌臨床治療新標(biāo)準(zhǔn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bdbd4868512)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
